Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

China flag China · Delayed Price · Currency is CNY
19.20
+0.45 (2.40%)
Mar 10, 2026, 3:00 PM CST
57.38%
Market Cap 2.37B
Revenue (ttm) 113.23M
Net Income (ttm) -173.47M
Shares Out 123.20M
EPS (ttm) -1.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,287,428
Average Volume 1,922,674
Open 19.22
Previous Close 18.75
Day's Range 18.86 - 19.27
52-Week Range 9.98 - 31.20
Beta 0.14
RSI 44.40
Earnings Date Apr 23, 2026

About SHA:688670

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 449
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688670
Full Company Profile

Financial Performance

In 2025, SHA:688670's revenue was 113.23 million, an increase of 40.13% compared to the previous year's 80.80 million. Losses were -173.47 million, 85.5% more than in 2024.

Financial Statements

News

There is no news available yet.